https://oncoindex.org/pl/polska https://oncoindex.org/en/poland https://oncoindex.org/en/spain https://oncoindex.org/es/espana https://oncoindex.org/pl/polska/dla-pacjenta https://oncoindex.org/en/poland/for-patient https://oncoindex.org/en/spain/for-patient https://oncoindex.org/es/espana/para-el-paciente https://oncoindex.org/pl/polska/dla-eksperta https://oncoindex.org/en/poland/for-expert https://oncoindex.org/en/spain/for-expert https://oncoindex.org/es/espana/para-el-experto https://oncoindex.org/pl/polska/site/kontakt https://oncoindex.org/en/poland/site/contact https://oncoindex.org/en/spain/site/contact https://oncoindex.org/es/espana/site/contact https://oncoindex.org/pl/polska/site/dla-mediow https://oncoindex.org/en/poland/site/presscontact https://oncoindex.org/en/spain/site/presscontact https://oncoindex.org/pl/polska/site/podpisz-petycje https://oncoindex.org/en/poland/site/signthepetiton https://oncoindex.org/pl/polska/site/o-projekcie https://oncoindex.org/en/poland/site/abouttheproject https://oncoindex.org/en/spain/site/abouttheproject https://oncoindex.org/es/espana/site/acercadelproyecto https://oncoindex.org/pl/polska/nowotwor/986/chloniaki-nie-hodgkina https://oncoindex.org/en/poland/cancer/986/non-hodgkin-lymphoma https://oncoindex.org/en/spain/cancer/986/non-hodgkin-lymphoma https://oncoindex.org/es/espana/cancer/986/Linfomas-no-Hodgkin https://oncoindex.org/pl/polska/nowotwor/154/choroba-hodgkina https://oncoindex.org/en/poland/cancer/154/hodgkin-s-disease https://oncoindex.org/en/spain/cancer/154/hodgkin-s-disease https://oncoindex.org/es/espana/cancer/154/Enfermedad-de-Hodgkin https://oncoindex.org/pl/polska/nowotwor/981/ostra-bialaczka-limfoblastyczna https://oncoindex.org/en/poland/cancer/981/acute-lymphoid-leukemia https://oncoindex.org/en/spain/cancer/981/acute-lymphoid-leukemia https://oncoindex.org/es/espana/cancer/981/Leucemia-linfobl%C3%A1stica-aguda https://oncoindex.org/pl/polska/nowotwor/984/ostra-bialaczka-szpikowa https://oncoindex.org/en/poland/cancer/984/acute-myeloid-leukemia https://oncoindex.org/en/spain/cancer/984/acute-myeloid-leukemia https://oncoindex.org/es/espana/cancer/984/Leucemia-mieloide-aguda https://oncoindex.org/pl/polska/nowotwor/982/przewlekla-bialaczka-limfocytowa https://oncoindex.org/en/poland/cancer/982/chronic-lymphoid-leukemia https://oncoindex.org/en/spain/cancer/982/chronic-lymphoid-leukemia https://oncoindex.org/es/espana/cancer/982/Leucemia-linfoc%C3%ADtica-cr%C3%B3nica https://oncoindex.org/pl/polska/nowotwor/983/przewlekla-bialaczka-szpikowa https://oncoindex.org/en/poland/cancer/983/chronic-myeloid-leukemia https://oncoindex.org/en/spain/cancer/983/chronic-myeloid-leukemia https://oncoindex.org/es/espana/cancer/983/Leucemia-mieloide-cr%C3%B3nica https://oncoindex.org/pl/polska/nowotwor/113/rak-gruczolu-krokowego https://oncoindex.org/en/poland/cancer/113/malignant-prostate-cancer https://oncoindex.org/en/spain/cancer/113/malignant-prostate-cancer https://oncoindex.org/es/espana/cancer/113/C%C3%A1ncer-de-pr%C3%B3stata https://oncoindex.org/pl/polska/nowotwor/118/rak-jajnika https://oncoindex.org/en/poland/cancer/118/malignant-ovarian-cancer https://oncoindex.org/en/spain/cancer/118/malignant-ovarian-cancer https://oncoindex.org/es/espana/cancer/118/C%C3%A1ncer-de-ovarios https://oncoindex.org/pl/polska/nowotwor/109/rak-jelita-grubego-i-odbytnicy https://oncoindex.org/en/poland/cancer/109/colon-and-rectum-cancer https://oncoindex.org/en/spain/cancer/109/colon-and-rectum-cancer https://oncoindex.org/es/espana/cancer/109/C%C3%A1ncer-de-colon-y-recto https://oncoindex.org/pl/polska/nowotwor/987/rak-nerki https://oncoindex.org/en/poland/cancer/987/kidney-cancer https://oncoindex.org/en/spain/cancer/987/kidney-cancer https://oncoindex.org/es/espana/cancer/987/C%C3%A1ncer-de-ri%C3%B1%C3%B3n https://oncoindex.org/pl/polska/nowotwor/114/rak-pecherza-moczowego https://oncoindex.org/en/poland/cancer/114/malignant-bladder-cancer https://oncoindex.org/en/spain/cancer/114/malignant-bladder-cancer https://oncoindex.org/es/espana/cancer/114/C%C3%A1ncer-de-vejiga https://oncoindex.org/pl/polska/nowotwor/110/rak-piersi https://oncoindex.org/en/poland/cancer/110/malignant-breast-cancer https://oncoindex.org/en/spain/cancer/110/malignant-breast-cancer https://oncoindex.org/es/espana/cancer/110/C%C3%A1ncer-de-mama https://oncoindex.org/pl/polska/nowotwor/108/rak-tchawicy-pluca-i-oskrzela https://oncoindex.org/en/poland/cancer/108/tracheal-bronchus-and-lung-cancer https://oncoindex.org/en/spain/cancer/108/tracheal-bronchus-and-lung-cancer https://oncoindex.org/es/espana/cancer/108/C%C3%A1ncer-de-tr%C3%A1quea-pulm%C3%B3n-y-bronquios https://oncoindex.org/pl/polska/nowotwor/112/rak-trzustki https://oncoindex.org/en/poland/cancer/112/malignant-pancreatic-cancer https://oncoindex.org/en/spain/cancer/112/malignant-pancreatic-cancer https://oncoindex.org/es/espana/cancer/112/C%C3%A1ncer-de-p%C3%A1ncreas https://oncoindex.org/pl/polska/nowotwor/120/rak-watroby-i-przewodow-zolciowych-wewnatrzwatrobowych https://oncoindex.org/en/poland/cancer/120/liver-cancer https://oncoindex.org/en/spain/cancer/120/liver-cancer https://oncoindex.org/es/espana/cancer/120/C%C3%A1ncer-de-h%C3%ADgado-y-v%C3%ADas-biliares-intrahep%C3%A1ticas https://oncoindex.org/pl/polska/nowotwor/111/rak-zoladka https://oncoindex.org/en/poland/cancer/111/malignant-stomach-cancer https://oncoindex.org/en/spain/cancer/111/malignant-stomach-cancer https://oncoindex.org/es/espana/cancer/111/C%C3%A1ncer-de-est%C3%B3mago https://oncoindex.org/pl/polska/nowotwor/127/szpiczak-mnogi-i-nowotwory-z-komorek-plazmatycznych https://oncoindex.org/en/poland/cancer/127/multiple-myeloma-and-plasma-cell-neoplasms https://oncoindex.org/en/spain/cancer/127/multiple-myeloma-and-plasma-cell-neoplasms https://oncoindex.org/es/espana/cancer/127/Mieloma-m%C3%BAltiple-y-neoplasias-de-c%C3%A9lulas-plasm%C3%A1ticas https://oncoindex.org/pl/polska/substancja-czynna/111/acalabrutinib https://oncoindex.org/en/poland/active-substance/111/acalabrutinib https://oncoindex.org/en/spain/active-substance/111/acalabrutinib https://oncoindex.org/es/espana/sustancia-activa/111/acalabrutinib https://oncoindex.org/pl/polska/substancja-czynna/86/axicabtagene-ciloleucel https://oncoindex.org/en/poland/active-substance/86/axicabtagene-ciloleucel https://oncoindex.org/en/spain/active-substance/86/axicabtagene-ciloleucel https://oncoindex.org/es/espana/sustancia-activa/86/axicabtagene-ciloleucel https://oncoindex.org/pl/polska/substancja-czynna/149/brexucabtagene-autoleucel https://oncoindex.org/en/poland/active-substance/149/brexucabtagene-autoleucel https://oncoindex.org/en/spain/active-substance/149/brexucabtagene-autoleucel https://oncoindex.org/es/espana/sustancia-activa/149/brexucabtagene-autoleucel https://oncoindex.org/pl/polska/substancja-czynna/151/epcoritamab https://oncoindex.org/en/poland/active-substance/151/epcoritamab https://oncoindex.org/en/spain/active-substance/151/epcoritamab https://oncoindex.org/es/espana/sustancia-activa/151/epcoritamab https://oncoindex.org/pl/polska/substancja-czynna/153/glofitamab https://oncoindex.org/en/poland/active-substance/153/glofitamab https://oncoindex.org/en/spain/active-substance/153/glofitamab https://oncoindex.org/es/espana/sustancia-activa/153/glofitamab https://oncoindex.org/pl/polska/substancja-czynna/77/ibrutinib https://oncoindex.org/en/poland/active-substance/77/ibrutinib https://oncoindex.org/en/spain/active-substance/77/ibrutinib https://oncoindex.org/es/espana/sustancia-activa/77/ibrutinib https://oncoindex.org/pl/polska/substancja-czynna/56/lenalidomide https://oncoindex.org/en/poland/active-substance/56/lenalidomide https://oncoindex.org/en/spain/active-substance/56/lenalidomide https://oncoindex.org/es/espana/sustancia-activa/56/lenalidomide https://oncoindex.org/pl/polska/substancja-czynna/156/lisocabtagene-maraleucel https://oncoindex.org/en/poland/active-substance/156/lisocabtagene-maraleucel https://oncoindex.org/en/spain/active-substance/156/lisocabtagene-maraleucel https://oncoindex.org/es/espana/sustancia-activa/156/lisocabtagene-maraleucel https://oncoindex.org/pl/polska/substancja-czynna/157/loncastuximab-tesirine https://oncoindex.org/en/poland/active-substance/157/loncastuximab-tesirine https://oncoindex.org/en/spain/active-substance/157/loncastuximab-tesirine https://oncoindex.org/es/espana/sustancia-activa/157/loncastuximab-tesirine https://oncoindex.org/pl/polska/substancja-czynna/158/mosunetuzumab https://oncoindex.org/en/poland/active-substance/158/mosunetuzumab https://oncoindex.org/en/spain/active-substance/158/mosunetuzumab https://oncoindex.org/es/espana/sustancia-activa/158/mosunetuzumab https://oncoindex.org/pl/polska/substancja-czynna/75/obinutuzumab https://oncoindex.org/en/poland/active-substance/75/obinutuzumab https://oncoindex.org/en/spain/active-substance/75/obinutuzumab https://oncoindex.org/es/espana/sustancia-activa/75/obinutuzumab https://oncoindex.org/pl/polska/substancja-czynna/174/odronextamab https://oncoindex.org/en/poland/active-substance/174/odronextamab https://oncoindex.org/en/spain/active-substance/174/odronextamab https://oncoindex.org/es/espana/sustancia-activa/174/odronextamab https://oncoindex.org/pl/polska/substancja-czynna/159/pirtobrutinib https://oncoindex.org/en/poland/active-substance/159/pirtobrutinib https://oncoindex.org/en/spain/active-substance/159/pirtobrutinib https://oncoindex.org/es/espana/sustancia-activa/159/pirtobrutinib https://oncoindex.org/pl/polska/substancja-czynna/110/polatuzumab-vedotin https://oncoindex.org/en/poland/active-substance/110/polatuzumab-vedotin https://oncoindex.org/en/spain/active-substance/110/polatuzumab-vedotin https://oncoindex.org/es/espana/sustancia-activa/110/polatuzumab-vedotin https://oncoindex.org/pl/polska/substancja-czynna/162/tafasitamab https://oncoindex.org/en/poland/active-substance/162/tafasitamab https://oncoindex.org/en/spain/active-substance/162/tafasitamab https://oncoindex.org/es/espana/sustancia-activa/162/tafasitamab https://oncoindex.org/pl/polska/substancja-czynna/84/tisagenlecleucel https://oncoindex.org/en/poland/active-substance/84/tisagenlecleucel https://oncoindex.org/en/spain/active-substance/84/tisagenlecleucel https://oncoindex.org/es/espana/sustancia-activa/84/tisagenlecleucel https://oncoindex.org/pl/polska/substancja-czynna/165/zanubrutinib https://oncoindex.org/en/poland/active-substance/165/zanubrutinib https://oncoindex.org/en/spain/active-substance/165/zanubrutinib https://oncoindex.org/es/espana/sustancia-activa/165/zanubrutinib https://oncoindex.org/pl/polska/substancja-czynna/83/brentuximab-vedotin https://oncoindex.org/en/poland/active-substance/83/brentuximab-vedotin https://oncoindex.org/en/spain/active-substance/83/brentuximab-vedotin https://oncoindex.org/es/espana/sustancia-activa/83/brentuximab-vedotin https://oncoindex.org/pl/polska/substancja-czynna/18/nivolumab https://oncoindex.org/en/poland/active-substance/18/nivolumab https://oncoindex.org/en/spain/active-substance/18/nivolumab https://oncoindex.org/es/espana/sustancia-activa/18/nivolumab https://oncoindex.org/pl/polska/substancja-czynna/19/pembrolizumab https://oncoindex.org/en/poland/active-substance/19/pembrolizumab https://oncoindex.org/en/spain/active-substance/19/pembrolizumab https://oncoindex.org/es/espana/sustancia-activa/19/pembrolizumab https://oncoindex.org/pl/polska/substancja-czynna/71/blinatumomab https://oncoindex.org/en/poland/active-substance/71/blinatumomab https://oncoindex.org/en/spain/active-substance/71/blinatumomab https://oncoindex.org/es/espana/sustancia-activa/71/blinatumomab https://oncoindex.org/pl/polska/substancja-czynna/79/inotuzumab-ozogamicin https://oncoindex.org/en/poland/active-substance/79/inotuzumab-ozogamicin https://oncoindex.org/en/spain/active-substance/79/inotuzumab-ozogamicin https://oncoindex.org/es/espana/sustancia-activa/79/inotuzumab-ozogamicin https://oncoindex.org/pl/polska/substancja-czynna/60/ponatinib https://oncoindex.org/en/poland/active-substance/60/ponatinib https://oncoindex.org/en/spain/active-substance/60/ponatinib https://oncoindex.org/es/espana/sustancia-activa/60/ponatinib https://oncoindex.org/pl/polska/substancja-czynna/92/daunorubicin-cytarabine https://oncoindex.org/en/poland/active-substance/92/daunorubicin-cytarabine https://oncoindex.org/en/spain/active-substance/92/daunorubicin-cytarabine https://oncoindex.org/es/espana/sustancia-activa/92/daunorubicin-cytarabine https://oncoindex.org/pl/polska/substancja-czynna/64/decitabine https://oncoindex.org/en/poland/active-substance/64/decitabine https://oncoindex.org/en/spain/active-substance/64/decitabine https://oncoindex.org/es/espana/sustancia-activa/64/decitabine https://oncoindex.org/pl/polska/substancja-czynna/66/gemtuzumab-ozogamicin https://oncoindex.org/en/poland/active-substance/66/gemtuzumab-ozogamicin https://oncoindex.org/en/spain/active-substance/66/gemtuzumab-ozogamicin https://oncoindex.org/es/espana/sustancia-activa/66/gemtuzumab-ozogamicin https://oncoindex.org/pl/polska/substancja-czynna/119/gilteritinib https://oncoindex.org/en/poland/active-substance/119/gilteritinib https://oncoindex.org/en/spain/active-substance/119/gilteritinib https://oncoindex.org/es/espana/sustancia-activa/119/gilteritinib https://oncoindex.org/pl/polska/substancja-czynna/107/glasdegib https://oncoindex.org/en/poland/active-substance/107/glasdegib https://oncoindex.org/en/spain/active-substance/107/glasdegib https://oncoindex.org/es/espana/sustancia-activa/107/glasdegib https://oncoindex.org/pl/polska/substancja-czynna/155/ivosidenib https://oncoindex.org/en/poland/active-substance/155/ivosidenib https://oncoindex.org/en/spain/active-substance/155/ivosidenib https://oncoindex.org/es/espana/sustancia-activa/155/ivosidenib https://oncoindex.org/pl/polska/substancja-czynna/65/midostaurin https://oncoindex.org/en/poland/active-substance/65/midostaurin https://oncoindex.org/en/spain/active-substance/65/midostaurin https://oncoindex.org/es/espana/sustancia-activa/65/midostaurin https://oncoindex.org/pl/polska/substancja-czynna/160/quizartinib https://oncoindex.org/en/poland/active-substance/160/quizartinib https://oncoindex.org/en/spain/active-substance/160/quizartinib https://oncoindex.org/es/espana/sustancia-activa/160/quizartinib https://oncoindex.org/pl/polska/substancja-czynna/78/venetoclax https://oncoindex.org/en/poland/active-substance/78/venetoclax https://oncoindex.org/en/spain/active-substance/78/venetoclax https://oncoindex.org/es/espana/sustancia-activa/78/venetoclax https://oncoindex.org/pl/polska/substancja-czynna/76/idelalisib https://oncoindex.org/en/poland/active-substance/76/idelalisib https://oncoindex.org/en/spain/active-substance/76/idelalisib https://oncoindex.org/es/espana/sustancia-activa/76/idelalisib https://oncoindex.org/pl/polska/substancja-czynna/147/asciminib https://oncoindex.org/en/poland/active-substance/147/asciminib https://oncoindex.org/en/spain/active-substance/147/asciminib https://oncoindex.org/es/espana/sustancia-activa/147/asciminib https://oncoindex.org/pl/polska/substancja-czynna/61/bosutinib https://oncoindex.org/en/poland/active-substance/61/bosutinib https://oncoindex.org/en/spain/active-substance/61/bosutinib https://oncoindex.org/es/espana/sustancia-activa/61/bosutinib https://oncoindex.org/pl/polska/substancja-czynna/38/abiraterone https://oncoindex.org/en/poland/active-substance/38/abiraterone https://oncoindex.org/en/spain/active-substance/38/abiraterone https://oncoindex.org/es/espana/sustancia-activa/38/abiraterone https://oncoindex.org/pl/polska/substancja-czynna/98/apalutamide https://oncoindex.org/en/poland/active-substance/98/apalutamide https://oncoindex.org/en/spain/active-substance/98/apalutamide https://oncoindex.org/es/espana/sustancia-activa/98/apalutamide https://oncoindex.org/pl/polska/substancja-czynna/37/cabazitaxel https://oncoindex.org/en/poland/active-substance/37/cabazitaxel https://oncoindex.org/en/spain/active-substance/37/cabazitaxel https://oncoindex.org/es/espana/sustancia-activa/37/cabazitaxel https://oncoindex.org/pl/polska/substancja-czynna/105/darolutamide https://oncoindex.org/en/poland/active-substance/105/darolutamide https://oncoindex.org/en/spain/active-substance/105/darolutamide https://oncoindex.org/es/espana/sustancia-activa/105/darolutamide https://oncoindex.org/pl/polska/substancja-czynna/39/enzalutamide https://oncoindex.org/en/poland/active-substance/39/enzalutamide https://oncoindex.org/en/spain/active-substance/39/enzalutamide https://oncoindex.org/es/espana/sustancia-activa/39/enzalutamide https://oncoindex.org/pl/polska/substancja-czynna/45/olaparib https://oncoindex.org/en/poland/active-substance/45/olaparib https://oncoindex.org/en/spain/active-substance/45/olaparib https://oncoindex.org/es/espana/sustancia-activa/45/olaparib https://oncoindex.org/pl/polska/substancja-czynna/4/bevacizumab https://oncoindex.org/en/poland/active-substance/4/bevacizumab https://oncoindex.org/en/spain/active-substance/4/bevacizumab https://oncoindex.org/es/espana/sustancia-activa/4/bevacizumab https://oncoindex.org/pl/polska/substancja-czynna/46/niraparib https://oncoindex.org/en/poland/active-substance/46/niraparib https://oncoindex.org/en/spain/active-substance/46/niraparib https://oncoindex.org/es/espana/sustancia-activa/46/niraparib https://oncoindex.org/pl/polska/substancja-czynna/47/rucaparib https://oncoindex.org/en/poland/active-substance/47/rucaparib https://oncoindex.org/en/spain/active-substance/47/rucaparib https://oncoindex.org/es/espana/sustancia-activa/47/rucaparib https://oncoindex.org/pl/polska/substancja-czynna/27/aflibercept https://oncoindex.org/en/poland/active-substance/27/aflibercept https://oncoindex.org/en/spain/active-substance/27/aflibercept https://oncoindex.org/es/espana/sustancia-activa/27/aflibercept https://oncoindex.org/pl/polska/substancja-czynna/140/encorafenib https://oncoindex.org/en/poland/active-substance/140/encorafenib https://oncoindex.org/en/spain/active-substance/140/encorafenib https://oncoindex.org/es/espana/sustancia-activa/140/encorafenib https://oncoindex.org/pl/polska/substancja-czynna/118/entrectinib https://oncoindex.org/en/poland/active-substance/118/entrectinib https://oncoindex.org/en/spain/active-substance/118/entrectinib https://oncoindex.org/es/espana/sustancia-activa/118/entrectinib https://oncoindex.org/pl/polska/substancja-czynna/168/fruquintinib https://oncoindex.org/en/poland/active-substance/168/fruquintinib https://oncoindex.org/en/spain/active-substance/168/fruquintinib https://oncoindex.org/es/espana/sustancia-activa/168/fruquintinib https://oncoindex.org/pl/polska/substancja-czynna/120/ipilimumab https://oncoindex.org/en/poland/active-substance/120/ipilimumab https://oncoindex.org/en/spain/active-substance/120/ipilimumab https://oncoindex.org/es/espana/sustancia-activa/120/ipilimumab https://oncoindex.org/pl/polska/substancja-czynna/104/larotrectinib https://oncoindex.org/en/poland/active-substance/104/larotrectinib https://oncoindex.org/en/spain/active-substance/104/larotrectinib https://oncoindex.org/es/espana/sustancia-activa/104/larotrectinib https://oncoindex.org/pl/polska/substancja-czynna/16/ramucirumab https://oncoindex.org/en/poland/active-substance/16/ramucirumab https://oncoindex.org/en/spain/active-substance/16/ramucirumab https://oncoindex.org/es/espana/sustancia-activa/16/ramucirumab https://oncoindex.org/pl/polska/substancja-czynna/28/regorafenib https://oncoindex.org/en/poland/active-substance/28/regorafenib https://oncoindex.org/en/spain/active-substance/28/regorafenib https://oncoindex.org/es/espana/sustancia-activa/28/regorafenib https://oncoindex.org/pl/polska/substancja-czynna/32/tegafur-gimeracil-oteracil https://oncoindex.org/en/poland/active-substance/32/tegafur-gimeracil-oteracil https://oncoindex.org/en/spain/active-substance/32/tegafur-gimeracil-oteracil https://oncoindex.org/es/espana/sustancia-activa/32/tegafur-gimeracil-oteracil https://oncoindex.org/pl/polska/substancja-czynna/29/trifluridine-tipiracil-hydrochloride https://oncoindex.org/en/poland/active-substance/29/trifluridine-tipiracil-hydrochloride https://oncoindex.org/en/spain/active-substance/29/trifluridine-tipiracil-hydrochloride https://oncoindex.org/es/espana/sustancia-activa/29/trifluridine-tipiracil-hydrochloride https://oncoindex.org/pl/polska/substancja-czynna/112/axitinib https://oncoindex.org/en/poland/active-substance/112/axitinib https://oncoindex.org/en/spain/active-substance/112/axitinib https://oncoindex.org/es/espana/sustancia-activa/112/axitinib https://oncoindex.org/pl/polska/substancja-czynna/148/belzutifan https://oncoindex.org/en/poland/active-substance/148/belzutifan https://oncoindex.org/en/spain/active-substance/148/belzutifan https://oncoindex.org/es/espana/sustancia-activa/148/belzutifan https://oncoindex.org/pl/polska/substancja-czynna/113/cabozantinib https://oncoindex.org/en/poland/active-substance/113/cabozantinib https://oncoindex.org/en/spain/active-substance/113/cabozantinib https://oncoindex.org/es/espana/sustancia-activa/113/cabozantinib https://oncoindex.org/pl/polska/substancja-czynna/121/lenvatinib https://oncoindex.org/en/poland/active-substance/121/lenvatinib https://oncoindex.org/en/spain/active-substance/121/lenvatinib https://oncoindex.org/es/espana/sustancia-activa/121/lenvatinib https://oncoindex.org/pl/polska/substancja-czynna/122/pazopanib https://oncoindex.org/en/poland/active-substance/122/pazopanib https://oncoindex.org/en/spain/active-substance/122/pazopanib https://oncoindex.org/es/espana/sustancia-activa/122/pazopanib https://oncoindex.org/pl/polska/substancja-czynna/125/tivozanib-hydrochloride-monohydrate https://oncoindex.org/en/poland/active-substance/125/tivozanib-hydrochloride-monohydrate https://oncoindex.org/en/spain/active-substance/125/tivozanib-hydrochloride-monohydrate https://oncoindex.org/es/espana/sustancia-activa/125/tivozanib-hydrochloride-monohydrate https://oncoindex.org/pl/polska/substancja-czynna/23/atezolizumab https://oncoindex.org/en/poland/active-substance/23/atezolizumab https://oncoindex.org/en/spain/active-substance/23/atezolizumab https://oncoindex.org/es/espana/sustancia-activa/23/atezolizumab https://oncoindex.org/pl/polska/substancja-czynna/128/avelumab https://oncoindex.org/en/poland/active-substance/128/avelumab https://oncoindex.org/en/spain/active-substance/128/avelumab https://oncoindex.org/es/espana/sustancia-activa/128/avelumab https://oncoindex.org/pl/polska/substancja-czynna/91/durvalumab https://oncoindex.org/en/poland/active-substance/91/durvalumab https://oncoindex.org/en/spain/active-substance/91/durvalumab https://oncoindex.org/es/espana/sustancia-activa/91/durvalumab https://oncoindex.org/pl/polska/substancja-czynna/139/enfortumab-vedotin https://oncoindex.org/en/poland/active-substance/139/enfortumab-vedotin https://oncoindex.org/en/spain/active-substance/139/enfortumab-vedotin https://oncoindex.org/es/espana/sustancia-activa/139/enfortumab-vedotin https://oncoindex.org/pl/polska/substancja-czynna/152/erdafitinib https://oncoindex.org/en/poland/active-substance/152/erdafitinib https://oncoindex.org/en/spain/active-substance/152/erdafitinib https://oncoindex.org/es/espana/sustancia-activa/152/erdafitinib https://oncoindex.org/pl/polska/substancja-czynna/90/abemaciclib https://oncoindex.org/en/poland/active-substance/90/abemaciclib https://oncoindex.org/en/spain/active-substance/90/abemaciclib https://oncoindex.org/es/espana/sustancia-activa/90/abemaciclib https://oncoindex.org/pl/polska/substancja-czynna/106/alpelisib https://oncoindex.org/en/poland/active-substance/106/alpelisib https://oncoindex.org/en/spain/active-substance/106/alpelisib https://oncoindex.org/es/espana/sustancia-activa/106/alpelisib https://oncoindex.org/pl/polska/substancja-czynna/176/capivasertib https://oncoindex.org/en/poland/active-substance/176/capivasertib https://oncoindex.org/en/spain/active-substance/176/capivasertib https://oncoindex.org/es/espana/sustancia-activa/176/capivasertib https://oncoindex.org/pl/polska/substancja-czynna/177/datopotamab-deruxtecan https://oncoindex.org/en/poland/active-substance/177/datopotamab-deruxtecan https://oncoindex.org/en/spain/active-substance/177/datopotamab-deruxtecan https://oncoindex.org/es/espana/sustancia-activa/177/datopotamab-deruxtecan https://oncoindex.org/pl/polska/substancja-czynna/145/elacestrant https://oncoindex.org/en/poland/active-substance/145/elacestrant https://oncoindex.org/en/spain/active-substance/145/elacestrant https://oncoindex.org/es/espana/sustancia-activa/145/elacestrant https://oncoindex.org/pl/polska/substancja-czynna/6/eribulin https://oncoindex.org/en/poland/active-substance/6/eribulin https://oncoindex.org/en/spain/active-substance/6/eribulin https://oncoindex.org/es/espana/sustancia-activa/6/eribulin https://oncoindex.org/pl/polska/substancja-czynna/5/everolimus https://oncoindex.org/en/poland/active-substance/5/everolimus https://oncoindex.org/en/spain/active-substance/5/everolimus https://oncoindex.org/es/espana/sustancia-activa/5/everolimus https://oncoindex.org/pl/polska/substancja-czynna/173/inavolisib https://oncoindex.org/en/poland/active-substance/173/inavolisib https://oncoindex.org/en/spain/active-substance/173/inavolisib https://oncoindex.org/es/espana/sustancia-activa/173/inavolisib https://oncoindex.org/pl/polska/substancja-czynna/88/neratinib https://oncoindex.org/en/poland/active-substance/88/neratinib https://oncoindex.org/en/spain/active-substance/88/neratinib https://oncoindex.org/es/espana/sustancia-activa/88/neratinib https://oncoindex.org/pl/polska/substancja-czynna/7/palbociclib https://oncoindex.org/en/poland/active-substance/7/palbociclib https://oncoindex.org/en/spain/active-substance/7/palbociclib https://oncoindex.org/es/espana/sustancia-activa/7/palbociclib https://oncoindex.org/pl/polska/substancja-czynna/3/pertuzumab https://oncoindex.org/en/poland/active-substance/3/pertuzumab https://oncoindex.org/en/spain/active-substance/3/pertuzumab https://oncoindex.org/es/espana/sustancia-activa/3/pertuzumab https://oncoindex.org/pl/polska/substancja-czynna/8/ribociclib https://oncoindex.org/en/poland/active-substance/8/ribociclib https://oncoindex.org/en/spain/active-substance/8/ribociclib https://oncoindex.org/es/espana/sustancia-activa/8/ribociclib https://oncoindex.org/pl/polska/substancja-czynna/135/sacituzumab-govitecan https://oncoindex.org/en/poland/active-substance/135/sacituzumab-govitecan https://oncoindex.org/en/spain/active-substance/135/sacituzumab-govitecan https://oncoindex.org/es/espana/sustancia-activa/135/sacituzumab-govitecan https://oncoindex.org/pl/polska/substancja-czynna/100/talazoparib https://oncoindex.org/en/poland/active-substance/100/talazoparib https://oncoindex.org/en/spain/active-substance/100/talazoparib https://oncoindex.org/es/espana/sustancia-activa/100/talazoparib https://oncoindex.org/pl/polska/substancja-czynna/127/trastuzumab-deruxtecan https://oncoindex.org/en/poland/active-substance/127/trastuzumab-deruxtecan https://oncoindex.org/en/spain/active-substance/127/trastuzumab-deruxtecan https://oncoindex.org/es/espana/sustancia-activa/127/trastuzumab-deruxtecan https://oncoindex.org/pl/polska/substancja-czynna/9/trastuzumab-emtansine https://oncoindex.org/en/poland/active-substance/9/trastuzumab-emtansine https://oncoindex.org/en/spain/active-substance/9/trastuzumab-emtansine https://oncoindex.org/es/espana/sustancia-activa/9/trastuzumab-emtansine https://oncoindex.org/pl/polska/substancja-czynna/136/tucatinib https://oncoindex.org/en/poland/active-substance/136/tucatinib https://oncoindex.org/en/spain/active-substance/136/tucatinib https://oncoindex.org/es/espana/sustancia-activa/136/tucatinib https://oncoindex.org/pl/polska/substancja-czynna/146/adagrasib https://oncoindex.org/en/poland/active-substance/146/adagrasib https://oncoindex.org/en/spain/active-substance/146/adagrasib https://oncoindex.org/es/espana/sustancia-activa/146/adagrasib https://oncoindex.org/pl/polska/substancja-czynna/14/afatinib https://oncoindex.org/en/poland/active-substance/14/afatinib https://oncoindex.org/en/spain/active-substance/14/afatinib https://oncoindex.org/es/espana/sustancia-activa/14/afatinib https://oncoindex.org/pl/polska/substancja-czynna/22/alectinib https://oncoindex.org/en/poland/active-substance/22/alectinib https://oncoindex.org/en/spain/active-substance/22/alectinib https://oncoindex.org/es/espana/sustancia-activa/22/alectinib https://oncoindex.org/pl/polska/substancja-czynna/142/amivantamab https://oncoindex.org/en/poland/active-substance/142/amivantamab https://oncoindex.org/en/spain/active-substance/142/amivantamab https://oncoindex.org/es/espana/sustancia-activa/142/amivantamab https://oncoindex.org/pl/polska/substancja-czynna/169/binimetinib https://oncoindex.org/en/poland/active-substance/169/binimetinib https://oncoindex.org/en/spain/active-substance/169/binimetinib https://oncoindex.org/es/espana/sustancia-activa/169/binimetinib https://oncoindex.org/pl/polska/substancja-czynna/97/brigatinib https://oncoindex.org/en/poland/active-substance/97/brigatinib https://oncoindex.org/en/spain/active-substance/97/brigatinib https://oncoindex.org/es/espana/sustancia-activa/97/brigatinib https://oncoindex.org/pl/polska/substancja-czynna/141/capmatinib https://oncoindex.org/en/poland/active-substance/141/capmatinib https://oncoindex.org/en/spain/active-substance/141/capmatinib https://oncoindex.org/es/espana/sustancia-activa/141/capmatinib https://oncoindex.org/pl/polska/substancja-czynna/132/cemiplimab https://oncoindex.org/en/poland/active-substance/132/cemiplimab https://oncoindex.org/en/spain/active-substance/132/cemiplimab https://oncoindex.org/es/espana/sustancia-activa/132/cemiplimab https://oncoindex.org/pl/polska/substancja-czynna/17/ceritinib https://oncoindex.org/en/poland/active-substance/17/ceritinib https://oncoindex.org/en/spain/active-substance/17/ceritinib https://oncoindex.org/es/espana/sustancia-activa/17/ceritinib https://oncoindex.org/pl/polska/substancja-czynna/13/crizotinib https://oncoindex.org/en/poland/active-substance/13/crizotinib https://oncoindex.org/en/spain/active-substance/13/crizotinib https://oncoindex.org/es/espana/sustancia-activa/13/crizotinib https://oncoindex.org/pl/polska/substancja-czynna/31/dabrafenib https://oncoindex.org/en/poland/active-substance/31/dabrafenib https://oncoindex.org/en/spain/active-substance/31/dabrafenib https://oncoindex.org/es/espana/sustancia-activa/31/dabrafenib https://oncoindex.org/pl/polska/substancja-czynna/101/dacomitinib https://oncoindex.org/en/poland/active-substance/101/dacomitinib https://oncoindex.org/en/spain/active-substance/101/dacomitinib https://oncoindex.org/es/espana/sustancia-activa/101/dacomitinib https://oncoindex.org/pl/polska/substancja-czynna/170/lazertinib https://oncoindex.org/en/poland/active-substance/170/lazertinib https://oncoindex.org/en/spain/active-substance/170/lazertinib https://oncoindex.org/es/espana/sustancia-activa/170/lazertinib https://oncoindex.org/pl/polska/substancja-czynna/102/lorlatinib https://oncoindex.org/en/poland/active-substance/102/lorlatinib https://oncoindex.org/en/spain/active-substance/102/lorlatinib https://oncoindex.org/es/espana/sustancia-activa/102/lorlatinib https://oncoindex.org/pl/polska/substancja-czynna/24/nab-paclitaxel https://oncoindex.org/en/poland/active-substance/24/nab-paclitaxel https://oncoindex.org/en/spain/active-substance/24/nab-paclitaxel https://oncoindex.org/es/espana/sustancia-activa/24/nab-paclitaxel https://oncoindex.org/pl/polska/substancja-czynna/15/nintedanib https://oncoindex.org/en/poland/active-substance/15/nintedanib https://oncoindex.org/en/spain/active-substance/15/nintedanib https://oncoindex.org/es/espana/sustancia-activa/15/nintedanib https://oncoindex.org/pl/polska/substancja-czynna/20/osimertinib https://oncoindex.org/en/poland/active-substance/20/osimertinib https://oncoindex.org/en/spain/active-substance/20/osimertinib https://oncoindex.org/es/espana/sustancia-activa/20/osimertinib https://oncoindex.org/pl/polska/substancja-czynna/161/repotrectinib https://oncoindex.org/en/poland/active-substance/161/repotrectinib https://oncoindex.org/en/spain/active-substance/161/repotrectinib https://oncoindex.org/es/espana/sustancia-activa/161/repotrectinib https://oncoindex.org/pl/polska/substancja-czynna/134/selpercatinib https://oncoindex.org/en/poland/active-substance/134/selpercatinib https://oncoindex.org/en/spain/active-substance/134/selpercatinib https://oncoindex.org/es/espana/sustancia-activa/134/selpercatinib https://oncoindex.org/pl/polska/substancja-czynna/143/sotorasib https://oncoindex.org/en/poland/active-substance/143/sotorasib https://oncoindex.org/en/spain/active-substance/143/sotorasib https://oncoindex.org/es/espana/sustancia-activa/143/sotorasib https://oncoindex.org/pl/polska/substancja-czynna/171/sugemalimab https://oncoindex.org/en/poland/active-substance/171/sugemalimab https://oncoindex.org/en/spain/active-substance/171/sugemalimab https://oncoindex.org/es/espana/sustancia-activa/171/sugemalimab https://oncoindex.org/pl/polska/substancja-czynna/137/tepotinib https://oncoindex.org/en/poland/active-substance/137/tepotinib https://oncoindex.org/en/spain/active-substance/137/tepotinib https://oncoindex.org/es/espana/sustancia-activa/137/tepotinib https://oncoindex.org/pl/polska/substancja-czynna/172/tislelizumab https://oncoindex.org/en/poland/active-substance/172/tislelizumab https://oncoindex.org/en/spain/active-substance/172/tislelizumab https://oncoindex.org/es/espana/sustancia-activa/172/tislelizumab https://oncoindex.org/pl/polska/substancja-czynna/30/trametinib https://oncoindex.org/en/poland/active-substance/30/trametinib https://oncoindex.org/en/spain/active-substance/30/trametinib https://oncoindex.org/es/espana/sustancia-activa/30/trametinib https://oncoindex.org/pl/polska/substancja-czynna/144/tremelimumab https://oncoindex.org/en/poland/active-substance/144/tremelimumab https://oncoindex.org/en/spain/active-substance/144/tremelimumab https://oncoindex.org/es/espana/sustancia-activa/144/tremelimumab https://oncoindex.org/pl/polska/substancja-czynna/35/irinotecan-hydrochloride-trihydrate https://oncoindex.org/en/poland/active-substance/35/irinotecan-hydrochloride-trihydrate https://oncoindex.org/en/spain/active-substance/35/irinotecan-hydrochloride-trihydrate https://oncoindex.org/es/espana/sustancia-activa/35/irinotecan-hydrochloride-trihydrate https://oncoindex.org/pl/polska/substancja-czynna/94/trastuzumab https://oncoindex.org/en/poland/active-substance/94/trastuzumab https://oncoindex.org/en/spain/active-substance/94/trastuzumab https://oncoindex.org/es/espana/sustancia-activa/94/trastuzumab https://oncoindex.org/pl/polska/substancja-czynna/167/zolbetuximab https://oncoindex.org/en/poland/active-substance/167/zolbetuximab https://oncoindex.org/en/spain/active-substance/167/zolbetuximab https://oncoindex.org/es/espana/sustancia-activa/167/zolbetuximab https://oncoindex.org/pl/polska/substancja-czynna/130/belantamab-mafodotin https://oncoindex.org/en/poland/active-substance/130/belantamab-mafodotin https://oncoindex.org/en/spain/active-substance/130/belantamab-mafodotin https://oncoindex.org/es/espana/sustancia-activa/130/belantamab-mafodotin https://oncoindex.org/pl/polska/substancja-czynna/53/carfilzomib https://oncoindex.org/en/poland/active-substance/53/carfilzomib https://oncoindex.org/en/spain/active-substance/53/carfilzomib https://oncoindex.org/es/espana/sustancia-activa/53/carfilzomib https://oncoindex.org/pl/polska/substancja-czynna/150/ciltacabtagene-autoleucel https://oncoindex.org/en/poland/active-substance/150/ciltacabtagene-autoleucel https://oncoindex.org/en/spain/active-substance/150/ciltacabtagene-autoleucel https://oncoindex.org/es/espana/sustancia-activa/150/ciltacabtagene-autoleucel https://oncoindex.org/pl/polska/substancja-czynna/49/daratumumab https://oncoindex.org/en/poland/active-substance/49/daratumumab https://oncoindex.org/en/spain/active-substance/49/daratumumab https://oncoindex.org/es/espana/sustancia-activa/49/daratumumab https://oncoindex.org/pl/polska/substancja-czynna/50/elotuzumab https://oncoindex.org/en/poland/active-substance/50/elotuzumab https://oncoindex.org/en/spain/active-substance/50/elotuzumab https://oncoindex.org/es/espana/sustancia-activa/50/elotuzumab https://oncoindex.org/pl/polska/substancja-czynna/166/elranatamab https://oncoindex.org/en/poland/active-substance/166/elranatamab https://oncoindex.org/en/spain/active-substance/166/elranatamab https://oncoindex.org/es/espana/sustancia-activa/166/elranatamab https://oncoindex.org/pl/polska/substancja-czynna/154/idecabtagene-vicleucel https://oncoindex.org/en/poland/active-substance/154/idecabtagene-vicleucel https://oncoindex.org/en/spain/active-substance/154/idecabtagene-vicleucel https://oncoindex.org/es/espana/sustancia-activa/154/idecabtagene-vicleucel https://oncoindex.org/pl/polska/substancja-czynna/108/isatuximab https://oncoindex.org/en/poland/active-substance/108/isatuximab https://oncoindex.org/en/spain/active-substance/108/isatuximab https://oncoindex.org/es/espana/sustancia-activa/108/isatuximab https://oncoindex.org/pl/polska/substancja-czynna/55/ixazomib https://oncoindex.org/en/poland/active-substance/55/ixazomib https://oncoindex.org/en/spain/active-substance/55/ixazomib https://oncoindex.org/es/espana/sustancia-activa/55/ixazomib https://oncoindex.org/pl/polska/substancja-czynna/175/linvoseltamab https://oncoindex.org/en/poland/active-substance/175/linvoseltamab https://oncoindex.org/en/spain/active-substance/175/linvoseltamab https://oncoindex.org/es/espana/sustancia-activa/175/linvoseltamab https://oncoindex.org/pl/polska/substancja-czynna/52/pomalidomide https://oncoindex.org/en/poland/active-substance/52/pomalidomide https://oncoindex.org/en/spain/active-substance/52/pomalidomide https://oncoindex.org/es/espana/sustancia-activa/52/pomalidomide https://oncoindex.org/pl/polska/substancja-czynna/131/selinexor https://oncoindex.org/en/poland/active-substance/131/selinexor https://oncoindex.org/en/spain/active-substance/131/selinexor https://oncoindex.org/es/espana/sustancia-activa/131/selinexor https://oncoindex.org/pl/polska/substancja-czynna/163/talquetamab https://oncoindex.org/en/poland/active-substance/163/talquetamab https://oncoindex.org/en/spain/active-substance/163/talquetamab https://oncoindex.org/es/espana/sustancia-activa/163/talquetamab https://oncoindex.org/pl/polska/substancja-czynna/164/teclistamab https://oncoindex.org/en/poland/active-substance/164/teclistamab https://oncoindex.org/en/spain/active-substance/164/teclistamab https://oncoindex.org/es/espana/sustancia-activa/164/teclistamab